Renal and hypotensive effects of acute and chronic oral treatment with 1-hydrazinophthalazine (apresoline) in hypertension.
D000284:Administration, Oral; D006801:Humans; D006830:Hydralazine; D006973:Hypertension / Q000628:therapy*; D007022:Hypotension; D007668:Kidney / Q000187:drug effects*; D013565:Sympatholytics / Q000627:therapeutic use*
D013565:Sympatholytics; D006830:Hydralazine
HYPERTENSION/therapy; KIDNEYS/effect of drugs on; SYMPATHOLYTICS/therapeutic use